American Academy of Dermatology 2024 Conference Review

In this issue:

Therapies for chronic GVHD
Therapies for advanced CTCL
Lutikizumab for HS
Remibrutinib for HS
FRONTIER-2: JNJ-77242113 for plaque psoriasis
DELTA-3: delgocitinib for chronic hand eczema
Upadacitinib for non-segmental vitiligo
AEs with JAK inhibitors
Atopic dermatitis & childhood growth
Maternal HS & offspring outcomes

Please login below to download this issue (PDF)